178 related articles for article (PubMed ID: 11902299)
1. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.
Mitchell AE; Elder JE; Mackey DA; Waters KD; Ashley DM
J Pediatr Hematol Oncol; 2001 Dec; 23(9):572-7. PubMed ID: 11902299
[TBL] [Abstract][Full Text] [Related]
2. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
3. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of carboplatin in children with progressive low-grade gliomas.
Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study.
Aquino VM; Fort DW; Kamen BA
J Neurooncol; 1999 Feb; 41(3):255-9. PubMed ID: 10359145
[TBL] [Abstract][Full Text] [Related]
6. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
[TBL] [Abstract][Full Text] [Related]
7. Visual Function, Brain Imaging, and Physiological Factors in Children With Asymmetric Nystagmus due to Chiasmal Gliomas.
Estrada M; Kelly JP; Wright J; Phillips JO; Weiss A
Pediatr Neurol; 2019 Aug; 97():30-37. PubMed ID: 31113715
[TBL] [Abstract][Full Text] [Related]
8. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy.
Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
Strahlenther Onkol; 2003 Aug; 179(8):509-20. PubMed ID: 14509949
[TBL] [Abstract][Full Text] [Related]
9. The clinical presentation of children with tumours affecting the anterior visual pathways.
Suharwardy J; Elston J
Eye (Lond); 1997; 11 ( Pt 6)():838-44. PubMed ID: 9537141
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
11. Visual loss in childhood.
Liu GT
Surv Ophthalmol; 2001; 46(1):35-42. PubMed ID: 11525788
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
Mahoney DH; Cohen ME; Friedman HS; Kepner JL; Gemer L; Langston JW; James HE; Duffner PK; Kun LE
Neuro Oncol; 2000 Oct; 2(4):213-20. PubMed ID: 11265230
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital.
Walter AW; Gajjar A; Reardon DA; Thompson SJ; Langston JW; Jones-Wallace D; Kun LE; Heideman RL
J Pediatr Hematol Oncol; 2000; 22(3):247-51. PubMed ID: 10864056
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin-induced regression of an optic pathway tumor in a child with neurofibromatosis.
Charrow J; Listernick R; Greenwald MJ; Das L; Radkowski MA
Med Pediatr Oncol; 1993; 21(9):680-4. PubMed ID: 8413004
[TBL] [Abstract][Full Text] [Related]
15. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
Falzon K; Drimtzias E; Picton S; Simmons I
Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience.
Heath JA; Turner CD; Poussaint TY; Scott RM; Goumnerova L; Kieran MW
Pediatr Hematol Oncol; 2003; 20(7):497-504. PubMed ID: 12959854
[TBL] [Abstract][Full Text] [Related]
17. Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: case report and literature review.
Mantadakis E; Raissaki M; Danilatou V; Kambourakis A; Stiakaki E; Kalmanti M
J Neurooncol; 2004; 67(1-2):95-100. PubMed ID: 15072453
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
Packer RJ; Ater J; Allen J; Phillips P; Geyer R; Nicholson HS; Jakacki R; Kurczynski E; Needle M; Finlay J; Reaman G; Boyett JM
J Neurosurg; 1997 May; 86(5):747-54. PubMed ID: 9126887
[TBL] [Abstract][Full Text] [Related]
19. The role of surgery in optic pathway/hypothalamic gliomas in children.
Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
